Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact-Reference-Cited by-同舟云学术

Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact

Published:2013-12-26 Issue:6 Volume:164 Page:822-833
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bacher Ulrike¹,Haferlach Torsten¹,Schnittger Susanne¹,Zenger Melanie¹,Meggendorfer Manja¹,Jeromin Sabine¹,Roller Andreas¹,Grossmann Vera¹,Krauth Maria-Theresa¹²,Alpermann Tamara¹,Kern Wolfgang¹,Haferlach Claudia¹

Affiliation:

1. MLL Munich Leukemia Laboratory; Munich Germany

2. Division of Haematology and Haemostaseology; Department of Internal Medicine I; Medical University Vienna; Vienna Austria

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12710/fullpdf

Reference41 articles.

1. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters-an analysis of 3082 patients;Bacher;Blood,2008

2. Myelodysplastic syndromes (MDS) with 20q deletion show a high frequency of associated cytogenetic and molecular lesions with an association to U2AF1, SRSF2, and prognostically Adverse ASXL1 mutations;Bacher;Blood (ASH Annual Meeting Abstracts),2013

3. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG);Bench;Oncogene,2000

4. del(20q) in myeloid malignancies;Bilhou-Nabera;Atlas of Genetics and Cytogenetics in Oncology and Haematology,2000

5. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases;Braun;Leukemia Research,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH);Current Research in Translational Medicine;2023-10

2. Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion;Cancer Medicine;2023-07-05

3. Co-mutation ofASXL1andSF3B1Predicts Poorer Overall Survival Than IsolatedASXL1orSF3B1Mutations;In Vivo;2023

4. Comparative Characteristics of Cytogenetic Abnormalities in Different Types of Myelodysplastic Syndromes;Cytology and Genetics;2022-09-20

5. Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor;Frontiers in Immunology;2022-06-24